Boosting translational cancer research
![](https://ec.europa.eu/newsroom/repository/picture/2016-25/08_06_16_small_13907.jpg)
Related topics
Health Innovation Health, Demographic Change and Wellbeing Austria Belgium Estonia France Germany Greece Hungary Italy Latvia Netherlands Poland Portugal Slovak Republic Slovenia Spain Israel Norway Taiwan Turkeydate: 13/06/2016
Project: ERA-NET: Aligning national/regional tran...
acronym: TRANSCAN-2
See also: CORDIS
Transcan was set up in 2011 by public funding organisations supporting translational cancer research — research that aims to develop promising scientific leads into new ways of predicting, detecting and treating cancer. It spans 15 EU countries as well as Israel, Norway, Taiwan and Turkey. The partners funded 30 projects with a total of €33 million from national research budgets. Projects focus on various aspects of cancer prevention as well as biomarkers that enable personalised medicine.